Morning Overview on MSN

FDA urges alternatives to animal testing in early-stage drug development

The U.S. Food and Drug Administration is actively steering drug developers away from traditional animal studies and toward human-biology-based testing methods for monoclonal antibody programs. The ...
Applied Clinical Trials Online

FDA Issues Draft Guidance to Validate Non-Animal Testing Methods in Drug Development

The FDA has released a draft guidance outlining how drug developers can validate new approach methodologies (NAMs) as alternatives to animal testing in preclinical drug developmen ...
MedPage Today on MSN

FDA Proposes More Flexibility in Alternatives to Animal Testing in Drug Development

Non-animal testing methods could save drugmakers time and money, officials say ...
Healio

FDA efforts to reduce animal testing signal shift toward AI, organ-on-chip study methods

In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...

Qalitex Laboratories Achieves ISO 17025 Accreditation for Analytical Testing

A2LA-accredited Irvine lab explains why accredited vs. self-declared compliance determines COA acceptance by Amazon, ...